Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of GT Biopharma Inc (NASDAQ: GTBP) was $0.73 for the day, up 4.13% from the previous closing price of $0.7. In other words, the price has increased by $4.13 from its previous closing price. On the day, 0.73 million shares were traded. GTBP stock price reached its highest trading level at $0.7675 during the session, while it also had its lowest trading level at $0.6903.
Ratios:
Our analysis of GTBP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.70 and its Current Ratio is at 2.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, ROTH MKM on December 02, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On May 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
On April 13, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.B. Riley Securities initiated its Buy rating on April 13, 2021, with a $21 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTBP now has a Market Capitalization of 7807986 and an Enterprise Value of 5280986.
Stock Price History:
The Beta on a monthly basis for GTBP is 1.44, which has changed by -0.75202703 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, GTBP has reached a high of $4.10, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 3.34%, while the 200-Day Moving Average is calculated to be -59.82%.
Shares Statistics:
GTBP traded an average of 1.95M shares per day over the past three months and 2125970 shares per day over the past ten days. A total of 10.64M shares are outstanding, with a floating share count of 9.26M. Insiders hold about 12.92% of the company’s shares, while institutions hold 4.93% stake in the company. Shares short for GTBP as of 1761868800 were 1310410 with a Short Ratio of 0.67, compared to 1759190400 on 244248. Therefore, it implies a Short% of Shares Outstanding of 1310410 and a Short% of Float of 12.370000000000001.
Earnings Estimates
The dynamic stock of GT Biopharma Inc (GTBP) is currently attracting attention from 1.0 analysts actively involved in rating its market status.
Analysts are recommending an EPS of between -$1.66 and -$1.66 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is -$0.7, with 1.0 analysts recommending between -$0.7 and -$0.7.
